5 completed, 1 enrolling by invitation, 1 not yet recruiting, 1 unknown. 5 Phase 2, 3 Not applicable, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Enrolling by invitation 1, Unknown 1 |
| Not applicable | 3 | Completed 2, Not yet recruiting 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Enrolling by invitation 1, Unknown 1 |
Follow Cannabinol: new trials by email Literature Review of Cannabinol trials Research Report on Cannabinol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CannaRiver CBD Calm for Anxiety, Sleep, and Well-Being in Adults With Generalized Anxiety Disorder Cannabidiol (CBD) With Cannabinol (CBN) and Cannabigerol (CBG) Oral Tincture (CannaRiver CBD Calm) - Generalized Anxiety Disorder | Not applicable | Not yet recruiting | Associação Pan-Americana Multidisciplinar de Endocanabinologia | 60 | 2026-11-01 | 2026-09-18 |
| The Effectiveness of CBD and CBN in the Treatment of Facial Pain and Headache of Muscular Origin An aqueous solution containing CBD and CBN, The aqueous solution of placebo - Myalgia, Muscle Pain | Phase 2 / Phase 3 | Enrolling by invitation | Wroclaw Medical University | 42 | 2025-04-01 | 2026-03-06 |
| A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of Various Cannabinoids on Sleep Quality 2 mg THC + 2 mg CBN + 2 mg CBG + 10 mg CBD + 1 mg Melatonin, 10 mg THC + 5 mg CBN + 5 mg CBG + 20 mg CBD, 10 mg THC + 20 mg CBN + 5 mg CBG - Sleep Disturbance, Sleep Quality | Not applicable | Completed | Cannabis Science Innovations, LLC | 332 | 2023-12-01 | 2026-08-19 |
| Cannabinol Use in Patients With Insomnia Disorder 30 mg Cannabinol (CBN), 300 mg Cannabinol (CBN), Placebo - Insomnia Disorder | Phase 1 / Phase 2 | Completed | Woolcock Institute of Medical Research | 20 | 2022-08-24 | 2024-02-06 |
| A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality CBN and CBD - Healthy Adults | Phase 1 / Phase 2 | Completed | Canopy Growth Corporation | 301 | 2022-05-16 | 2023-05-03 |
| Assessing the Effects of a Cannabidiol Derived From Hemp Supplement in Healthy Adults Cannabinol, Placebo - Healthy, Safety Issues | Not applicable | Completed | University of South Carolina | 56 | 2022-01-18 | 2022-11-01 |
| INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa INM-755 (cannabinol) cream, Vehicle Cream - Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, Junctional | Phase 2 | Completed | InMed Pharmaceuticals Inc. | 19 | 2021-12-28 | 2023-07-03 |
| COPE: Cannabinoids to Obviate Pain Experiment After Knee Replacement Cannabinol, Placebo oral capsule - Arthroplasty, Replacement, Knee | Phase 2 / Phase 3 | Unknown | Unity Health Toronto | 220 | 2020-05-01 | 2019-10-01 |
Sleep Initiation and Maintenance Disorders (3) · Agnosia (1) · Epidermolysis Bullosa Dystrophica (1) · Epidermolysis Bullosa Simplex (1) · Epidermolysis Bullosa, Junctional (1) · Facial Pain (1) · Generalized Anxiety Disorder (1) · Headache (1) · Marijuana Abuse (1) · Myalgia (1) · Parasomnias (1) · Poikiloderma of Kindler (1) · Psychological Well-Being (1) · Tension-Type Headache (1)
Associação Pan-Americana Multidisciplinar de Endocanabinologia (1) · Cannabis Science Innovations, LLC (1) · Canopy Growth Corporation (1) · InMed Pharmaceuticals Inc. (1) · Unity Health Toronto (1) · University of South Carolina (1) · Woolcock Institute of Medical Research (1) · Wroclaw Medical University (1)
United States (3) · Australia (1) · Canada (1) · France (1) · Germany (1) · Greece (1) · Israel (1) · Italy (1) · Poland (1)
Alexandra DJ Mancini, MSc (1) · Amit Atrey, MD (1) · Brendon Yee, MBChB, FRACP, FCCP, PhD (1) · Camilla Hoyos, MPH, PhD (1) · Marcel O Bonn-Miller, PhD (1) · Matthew T Feldner, PhD (1)